In Case You Missed It: IDWeek 2022 – Day 3

Today is the third day of IDWeek 2022. If you happen to be at the conference and missed our posts last week, here is a quick guide to UNMC members presenting today, October 21st.


Friday, October 21st, 2022

  • 7:30-9:00am – Jasmine Marcelin, MD – Panelist on ” Women in ID”
  • 10:30-11:45am – Sara Bares, MD – Panelist on “Challenging HIV Clinical Cases”
  • 12:15pm-1:30pm – Poster Presentations
    • Bryan Alexander, PharmD – Clinical Outcomes and Cost Savings of Dalbavancin Use in OPAT: Focus on Complicated Staphylococcus aureus Infections
    • Anum Abbas, MD – Cerebrospinal Fluid Findings of Solid Organ Transplant Recipients with West Nile Virus Infections
    • Nikki Regan, APRN – Telehealth Utilization and 2-year Outcomes among People with HIV at a Midwestern Clinic
    • Ryan Boyland, Medical Student – Curbsiding Twitter: Potential Value and Patient Confidentiality Implications of Infectious Diseases Clinician Peer Consultations via Social Media
    • Riley Ostdiek, Medical Student – A Highly Effective ID Physician and Infection Preventionist-led Interactive Webinar Series for Infection Prevention and Control Training Among Frontline Healthcare Workers
    • Titilola Labisi, MHA, MPH – Telehealth Utilization and 2-year Outcomes among People with HIV at a Midwestern Clinic
    • Josh Havens, PharmD – Patient perspectives on pharmacy experiences for antiretroviral refills
    • Timothy McElroy, MD – Local Antibiogram for Mycobacterium abscessus Shows Variability from Previously Published Susceptibility Data
    • Josh Havens, PharmD – B/F/TAF in HIV-Infected Adults with Substance Use Disorders: BASE Week 48 Results
    • Jeremy Tigh, PharmD – Acute Kidney Injury Rates Before and After Implementation of Integrated Bayesian Software for Vancomycin Dosing
  • 3:15-3:40pm – Scott Bergman, PharmD – Speaking on “Influential Publications in Antimicrobial Stewardship From the Past Year”
  • 3:15-4:30pm – Kimberly Scarsi, PharmD – Moderating “Long-Acting ARVs: Real-World Outcomes”

twitter facebook bluesky email print

Leave a comment

Your email address will not be published. Required fields are marked *

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

KXOW F rTKvoEYvPW